Application 202308
- Type
- ANDA
- Sponsor
- SANDOZ INC
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | AZITHROMYCIN | AZITHROMYCIN | SOLUTION; OPHTHALMIC | 1% | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Azithromycin | AZITHROMYCIN | A-S Medication Solutions | 4278e306-bc26-4282-93ce-f1405e0b5d4a | 2024-06-12 | Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | Chartwell RX, LLC | 2c9de2e9-c20c-4660-a272-a22019f9fb02 | 2024-04-09 | Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | Proficient Rx LP | 44134421-cb0b-4e85-a3c8-d58bdb476fad | 2024-04-01 | Boxed warning, Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | STATE HEALTH SERVICES, TEXAS DEPARTMENT OF | 2b821631-0df2-0fb2-e054-00144ff8d46c | 2024-02-29 | Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | Asclemed USA, Inc. | b77b347d-d357-4bdf-b985-49d9a1dd634c | 2023-12-30 | Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | Bionpharma Inc. | a2754618-3df1-4b89-aa09-fdff4b71b7e4 | 2023-12-24 | Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | A-S Medication Solutions | 5ed68b5a-4093-49f1-871b-7b0da5f7be2d | 2023-10-31 | Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | Asclemed USA, Inc. | 9c44af6d-8a9a-cb4c-e053-2a95a90afdac | 2023-09-01 | Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | A-S Medication Solutions | af720986-48a9-48b5-bdd7-370f6a2f92e1 | 2023-04-24 | Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | Teva Pharmaceuticals USA, Inc. | f6a52c0b-45db-422e-8c22-e867a11b4439 | 2023-03-01 | Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | A-S Medication Solutions | 22a2bdcb-3012-42fb-ac66-d1d879100940 | 2023-02-06 | Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
| AZITHROMYCIN | AZITHROMYCIN | Alembic Pharmaceuticals Limited | 5dca5a11-3c02-4a51-a35d-f91f37b8e00c | 2023-01-27 | Warnings, Adverse reactions | AZITHROMYCIN AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | Alembic Pharmaceuticals Limited | d5c95c30-564f-4b67-ac6d-9179cdfaa5a8 | 2023-01-13 | Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | Alembic Pharmaceuticals Limited | deea1a56-84ed-4ce4-9d11-03271510c0a1 | 2023-01-12 | Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN DIHYDRATE | Slate Run Pharmaceuticals | 8acce3c1-f4be-4968-a71f-3ffd9fbaa4a4 | 2022-12-01 | Warnings, Adverse reactions | Azithromycin |
| AZITHROMYCIN | AZITHROMYCIN | Proficient Rx LP | e1172805-0930-4fb9-8a2f-e0d6a0430630 | 2022-11-01 | Warnings, Adverse reactions | AZITHROMYCIN AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | Proficient Rx LP | 34e6364a-ac3d-434e-a90c-cb13ebcf7983 | 2022-11-01 | Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN | Proficient Rx LP | 33140df5-420d-469f-b6c8-121e952a5cb6 | 2022-11-01 | Warnings, Adverse reactions | Azithromycin AZITHROMYCIN |
| AZITHROMYCIN | AZITHROMYCIN | Proficient Rx LP | b3761d39-9b79-4908-8b05-a1c91e599998 | 2022-11-01 | Warnings, Adverse reactions | AZITHROMYCIN AZITHROMYCIN |
| Azithromycin | AZITHROMYCIN MONOHYDRATE | PharmPak, Inc. | ba57ff26-cd02-4f57-ac92-b613d245a4ea | 2022-10-14 | Warnings, Adverse reactions | Azithromycin |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Documents#
| Document | Submission type | Date |
|---|---|---|
| 10019 | ORIG | 2014-02-26 |